Charles S. Fuchs's Insider Trades & SAST Disclosures

Charles S. Fuchs's most recent trade in CytomX Therapeutics Inc was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2020.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
CytomX Therapeutics Inc
Charles S. Fuchs Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2020 20,000 20,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades